Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    HYPEROXALURIA, PRIMARY, TYPE II
Show Display Options
Rank Status Study
1 Completed Endothelial Function in a Sample Group of Patients From the ICARE Study
Condition: Cardiovascular Diseases
Intervention: Drug: Vitamin E 400IU/day
2 Recruiting Biobank Protocol, Rare Diseases Clinical Research Network
Conditions: Primary Hyperoxaluria;   Dent Disease;   APRT Deficiency;   Cystinuria
Intervention:
3 Active, not recruiting Primary Hyperoxaluria Mutation Genotyping
Condition: Primary Hyperoxaluria
Intervention: Genetic: Genetic Analysis
4 Withdrawn International Registry for Primary Hyperoxaluria
Conditions: Primary Hyperoxaluria;   Nephrocalcinosis;   Kidney Stones
Intervention:

Indicates status has not been verified in more than two years